Pactiv Evergreen Inc. Common stock
PTVE
PTVE was delisted on the 31st of March, 2025.
111 hedge funds and large institutions have $322M invested in Pactiv Evergreen Inc. Common stock in 2023 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 49 increasing their positions, 37 reducing their positions, and 19 closing their positions.
4,800% more call options, than puts
Call options by funds: $98K | Put options by funds: $2K
32% more repeat investments, than reductions
Existing positions increased: 49 | Existing positions reduced: 37
7% more capital invested
Capital invested by funds: $301M → $322M (+$21.4M)
9% less funds holding
Funds holding: 122 → 111 (-11)
53% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 19
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCMNY
Rubric Capital Management (New York)
New York
|
+$1.51M |
| 2 |
Dimensional Fund Advisors
Austin,
Texas
|
+$1.32M |
| 3 |
ER
EVR Research
Richmond,
Virginia
|
+$1.31M |
| 4 |
FCM
Frontier Capital Management
Boston,
Massachusetts
|
+$714K |
| 5 |
Charles Schwab
San Francisco,
California
|
+$630K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$2.11M |
| 2 |
Millennium Management
New York
|
-$2.02M |
| 3 |
Bank of America
Charlotte,
North Carolina
|
-$1.13M |
| 4 |
Allianz Asset Management
Munich,
Germany
|
-$986K |
| 5 |
BlackRock
New York
|
-$287K |
PTVE Hedge Fund Activity: Q3 2023 in Review
111 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Pactiv Evergreen Inc. Common stock (PTVE) for Q3 2023, worth a combined $322M — up 7.1% from $301M a quarter earlier.
Sellers outnumbered buyers: 19 funds closed out of PTVE and 9 opened new positions — a net loss of 10 holders — while 37 trimmed existing stakes and 49 added.
The largest buyer was Rubric Capital Management (New York), adding an estimated $1.51M. The largest seller was Citadel Advisors, cutting an estimated $2.11M.
- 111 institutional investors held Pactiv Evergreen Inc. Common stock (PTVE) as of Q3 2023, down from 122 in Q2 2023.
- Funds reported $322M of Pactiv Evergreen Inc. Common stock stock for Q3 2023, up 7.1% quarter-over-quarter.
- 9 funds opened new Pactiv Evergreen Inc. Common stock positions in Q3 2023 and 19 closed out, a net change of -10 holders.
- The largest Pactiv Evergreen Inc. Common stock buyer in Q3 2023 was Rubric Capital Management (New York), an estimated $1.51M added.
- The largest Pactiv Evergreen Inc. Common stock seller in Q3 2023 was Citadel Advisors, an estimated $2.11M sold.
Based on aggregated 13F filings for Q3 2023.